Parallax Volatility Advisers’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Parallax Volatility Advisers’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1	Closed	–	–	3112
2019 Q2	$0	Hold	1	–	–	﹤0.01%	3379
2019 Q1	$0	Hold	1	–	–	﹤0.01%	3657
2018 Q4	$0	Hold	1	–	–	﹤0.01%	3621
2018 Q3	$0	Hold	1	–	–	﹤0.01%	3279
2018 Q2	$0	Hold	1	–	–	﹤0.01%	2943
2018 Q1	$0	Hold	1	–	–	﹤0.01%	3668
2017 Q4	$0	Hold	1	–	–	﹤0.01%	4620
2017 Q3	$0	Hold	1	–	–	﹤0.01%	2902
2017 Q2	$0	Hold	1	–	–	﹤0.01%	3447
2017 Q1	$0	Hold	1	–	–	﹤0.01%	4316
2016 Q4	$0	Hold	1	–	–	﹤0.01%	3810
2016 Q3	$0	Hold	1	–	–	﹤0.01%	3611
2016 Q2	$0	Hold	1	–	–	﹤0.01%	3222
2016 Q1	$0	Hold	1	–	–	﹤0.01%	3322
2015 Q4	$0	Hold	1	–	–	﹤0.01%	3570
2015 Q3	$0	Hold	1	–	–	﹤0.01%	3751
2015 Q2	$0	Hold	1	–	–	﹤0.01%	4539
2015 Q1	$0	Hold	1	–	–	﹤0.01%	5167
2014 Q4	$0	Buy	+1	New	+$49	﹤0.01%	5583

Other funds holding PBE

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

Parallax Volatility Advisers's PBE Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2019, closing a stake of 1 share.

Parallax Volatility Advisers first reported a position in PBE in Q4 2014 and held it in 19 quarters. The position peaked at $0 in Q2 2019. 73 funds tracked by Wall St. Rank hold PBE as of Q3 2019.

Parallax Volatility Advisers reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 1 Invesco Biotechnology & Genome ETF share in Q3 2019.
Parallax Volatility Advisers first reported a position in Invesco Biotechnology & Genome ETF in Q4 2014 and held it in 19 quarters.
Parallax Volatility Advisers's Invesco Biotechnology & Genome ETF position peaked at $0 in Q2 2019.
73 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.